Kathryn North

Group Leader, Neuromuscular Research; Chief Investigator, Australian Genomic Health Alliance

Murdoch Childrens Research Institute

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kathryn North is a Group Leader in Neuromuscular Research and Chief Investigator at the Australian Genomic Health Alliance, based at the Murdoch Childrens Research Institute in Australia. Her research focuses on the integration of genomics into healthcare and the pediatric implications of various genetic conditions. Recent publications include studies on telehealth in pediatric neuropsychology, the role of genomics in rare diseases, and the longitudinal tracking of birth cohorts. Dr. North is actively involved in initiatives aimed at enhancing the understanding and treatment of rare pediatric disorders.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (17)

Oliver Hofmann

Associate Professor

University of Melbourne

AUSTRALIA

Kathryn North

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Using implementation science to navigate the complexity of integrating genomics into healthcare

Generation of an iPSC line (with isogenic control) from the PBMCs of a COL6A1 (c.1056 + 2T > A) Bethlem myopathy patient

A call to action to scale up research and clinical genomic data sharing

The expanding global genomics landscape: Converging priorities from national genomics programs.

Agreement, reliability, feasibility, and acceptability of home-based telehealth versus face-to-face pediatric neuropsychological testing: A within-person crossover study.

International Precision Child Health Partnership (IPCHiP): an initiative to accelerate discovery and improve outcomes in rare pediatric disease.

Generation Victoria (GenV): protocol for a longitudinal birth cohort of Victorian children and their parents.

Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing

Consensus reporting guidelines to address gaps in descriptions of ultra-rare genetic conditions

Brain volumes in genetic syndromes associated with mTOR dysregulation: a systematic review and meta-analysis.

Australian Genomics

Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1

Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1

Aligning intuition and theory: a novel approach to identifying the determinants of behaviours necessary to support implementation of evidence into practice

Integrated multi-omics for rapid rare disease diagnosis on a national scale.

Understanding nonliteral language abilities in children with neurofibromatosis type 1.

Delineating Visual Habituation Profiles in Preschoolers with Neurofibromatosis Type 1 and Autism Spectrum Disorder: A Cross-Syndrome Study

Sex- and age-related differences in autistic behaviours in children with neurofibromatosis type 1

Collaborators (17)

Oliver Hofmann

Stephanie Best

David Arthur Stroud

Melanie Porter

Darren Hocking

Naomi Allen

Jonathan Payne

Zornitza Stark

Avnika Ruparelia

Joshua Clayton

Karin Kassahn

Natalie Taylor

Janet Long

Nigel Laing

Jeffrey Braithwaite

Karin Walsh

Andrew J Mallett

Make your next move.